Insomnia in central neurologic diseases - occurrence and management

Sleep Medicine Reviews

Volumn 15, Issue 6, 2011, Pages 369-378

  Mayer, Geert ^a   Jennum, Poul ^b   Riemann, Dieter ^c   Dauvilliers, Yves ^d  

^a Hephata Klinik   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF FREIBURG   (Germany)

^d GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Central neurologic disease; Classification; Diagnostic criteria; Insomnia; Pathophysiology; Polysomnography; Therapy

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; HYPNOTIC AGENT; KETAMINE; LEVODOPA; LORAZEPAM; MELATONIN; METHYLPHENIDATE; MIANSERIN; OXAZEPAM; OXYBATE SODIUM; QUETIAPINE; SERTRALINE; TRIAZOLAM; ZOLPIDEM; ZOPICLONE;

ACTIMETRY; ALZHEIMER DISEASE; CIRCADIAN RHYTHM SLEEP DISORDER; COCHRANE LIBRARY; COGNITIVE DEFECT; COGNITIVE THERAPY; DEMENTIA; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; EMBASE; EPILEPSY; EVIDENCE BASED MEDICINE; FATAL FAMILIAL INSOMNIA; HALLUCINATION; HEADACHE; HUMAN; INSOMNIA; INSTRUMENT VALIDATION; MEDICAL HISTORY; MEDLINE; MULTIPLE SCLEROSIS; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PHOTOTHERAPY; POLYSOMNOGRAPHY; PREVALENCE; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEDATION; SIDE EFFECT; SLEEP QUALITY; STROKE; SYSTEMATIC REVIEW (TOPIC); TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; CENTRAL NERVOUS SYSTEM DISEASES; DEMENTIA; EPILEPSY; HEADACHE; HUMANS; HYPNOTICS AND SEDATIVES; PARKINSON DISEASE; SLEEP INITIATION AND MAINTENANCE DISORDERS; STROKE;

EID: 82455192216     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2011.01.005     Document Type: Review

References (118)

1. Jennum P., Santamaria J., Bassetti C., Clarenbach P., Högl B., et al. Report of an EFNS task force on management of sleep disorders in neurologic disease (degenerative neurologic disorders and stroke). Eur J Neurol 2007, 14:1189-1200.
2. Alonso J., Vilagut G., Chatterji S., Heeringa S., Schoenbaum M., Bedirhan üstün T., et al. Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys. Psychol Med 2010, 16:1-14.
3. American Psychiatric Association DSM-IV: diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington, DC. 4th ed.
4. American Academy of Sleep Medicine. The international classification of sleep disorders 2nd ed. Westchester, IL, 2005.
5. Taylor D.J., Mallory L.J., Lichstein K.L., Durrence H.H., Riedel B.W., Bush A.J., et al. Co-morbidity of chronic insomnia with medical problems. Sleep 2007, 30(2):213-218.
6. Stanton B.R., Barnes F., Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006, 12:481-486.
7. Ouellet M.C., Beaulieu-Bonneau S., Morin C.M. Insomnia in patients with traumatic brain injury: frequency, characteristics, and risk factors. J Head Trauma Rehabil 2006, 21(3):199-212.
8. Standards of Practice Committee of the AmericanAcademy of Sleep Medicine Practice parameters for the evaluation of chronic insomnia. Sleep 2000, 23(2):237-241.
9. Riemann D., Spiegelhalder K., Feige B., Voderholzer U., Berger M., Perlis M., et al. The hyperarousal model of insomnia: A review of the concept and its evidence. Sleep Med Rev 2010, 14:19-31.
10. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
11. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
12. Luppi P.-H., Gervasoni D., Verret L., Goutagny R., Peyron C., Salvert D., et al. Paradoxical (REM) sleep genesis: the switch from an aminergic-cholinergic to a GABAergic-glutamatergic hypothesis. J Physiol 2007, 100:271-283.
13. Winkelman J.W., Buxton O.M., Jensen E., Benson K.L., O'Connor S.P., Wang W., et al. Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep 2008, 31:1499-1506.
14. Nofzinger E.A., Buysse D.J., Germain A., Price J.C., Miewald J.M., Kupfer D.J. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004, 161(11):2126-2128.
15. Koenigs M., Holliday J., Solomon J., Grafman J. Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 2010, 30(47):16041-16043.
16. Rutgers D.R., Toulgoat F., Cazejust J., Fillard P., Lasjaunias P., Ducreux D. White matter abnormalities in mild traumatic brain injury: a diffusion tensor imaging study. Am J Neuroradiol 2008, 29:514-519.
17. Cano G., Mochizuki T., Saper C.B. Neural circuitry of stress-induced insomnia in rats. J Neurosci 2008, 28:10167-10184.
18. Krasnianski A., Bartl M., Sanchez Juan P.J., Heinemann U., Meissner B., Varges D., et al. Fatal familial insomnia: clinical features and early identification. Ann Neurol 2008, 63(5):658-661.
19. Landolt H.P., Glatzel M., Blattler T., Achermann P., Roth C., Mathis J., et al. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology 2006, 66(9):1418-1424.
20. Montagna P. Fatal familial insomnia: a model disease in sleep physiopathology. Sleep Med Rev 2005, 9(5):339-353.
21. Lewy A.J., Ahmed S., Jackson J.M., Sack R.L. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992, 9:380-392.
22. Chee M.W., Tan J.C., Zheng H., Parimal S., Weissman D.H., Zagorodnov V., et al. Lapsing during sleep deprivation is associated with distributed changes in brain activation. J Neurosci 2008, 28(21):5519-5528.
23. Brainin M., Barnes M., Baron J.C., et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces-revised recommendations. Eur J Neurol 2004, 11:577-581. 2004.
24. Buysse D.J., Ancoli-Israel S., Edinger J., Lichstein K., Morin C.M. Recommendations for a standard research assessment of insomnia. Sleep 2006, 29:1155-1173.
25. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiat Res 1989, 28:193-213.
26. Douglass A., Bornstein R., Nino-Murcia G., Keenan S., Mile S.L., Zarcone V.P. The sleep disorders questionnaire i: creation and multivariate structure of SDQ. Sleep 1994, 17(2):160-167.
27. Bassetti C.L. Sleep and stroke. Semin Neurol 2005, 25(1):19-32.
28. Ohayon M.M., Guilleminault C., Paiva T., Priest R.G., Rapoport D.M., Sagales T., et al. An international study on sleep disorders in the general population: methodological aspects of the use of the SLEEP-EVAL system. Sleep 1997, 20:1086-1092.
29. Högl B., Arnulf I., Comella C., Ferreira J., Iranzo A., Tilley B., et al. Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 2010, 10.1002/mds.23190.
30. Martinez-Martin P., Visser M., Rodriguez-Blazquez C., Marinus J., Chaudhuri K.R., van Hilten J.J. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Mov Disord 2008, 23(12):1681-1688.
31. Van Someren E.J.W., Kessler A., Mirmiran M., Schwaab D.F. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997, 41:955-963.
32. Kushida C.A., Littner M.R., Morgenthaler T., Alessi C.A., Bauiley D., Coleman J., et al. Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 2005, 28:499-521.
33. Vgontzas A.N., Liao D., Pejovic S., Calhoun S., Karataraki M., Basta M., et al. Insomnia with short sleep duration and mortality: the Penn State cohort. Sleep 2010, 33(9):1159-1164.
34. Van Someren E. Improving actigraphic sleep estimates in insomnia and dementia: how many nights?. J Sleep Res 2007, 16:269-275.
35. Dauvilliers Y. Insomnia in patients with neurodegenerative conditions. Sleep Med 2007, 8(Suppl. 4):27-34.
36. Tandberg E., Larsen J.P., Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998, 13(6):895-899.
37. Gjerstad M.D., Wentzel-Larsen T., Aarsland T., Larsen J.P. Insomnia in Parkinson's disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007, 78:476-479.
38. Oerlemans W.G., de Weerd A.W. The prevalence of sleep disorders in patients with Parkinson's disease: a self-reported, community-based survey. Sleep Med 2002, 3:147-149.
39. Factor S.A., McAlarney T., Sanchez-Ramos J.R., Weiner W.J. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990, 5:280-285.
40. Verbaan D., van Rooden S.M., Visser M., Marinus J., van Hilten J.J. Nighttime sleep problems and daytime sleepiness in Parkinson's disease. Mov Disord 2008, 23(1):35-41.
41. Wetter T.C., Collado-Seidel V., Pollmächer T., Yassouridis A., Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000, 23(3):361-367.
42. Adler C.H., Thorpy M.J. Sleep issues in Parkinson's disease. Neurology 2005, 64(Suppl.):12-20.
43. Zesiewicz T.A., Sullivan K.L., Arnulf I., Chaudhuri K.R., Morgan J.C., Gronseth G.S., et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the quality standards Subcommittee of the American Academy of Neurology. Neurology 2010, 74(11):924-931.
44. Colosimo C., Morgante L., Antonini A., Barone P., Avarello T.P. Non motor symptoms in atypical and secondary parkinsonism: the Priamo study. J Neurol 2010, 257:5-14.
45. Montplaisir J., Petit D., Décary A., Masson H., Bédard M.A., Panisset M., et al. Sleep and quantitative EEG in patients with progressive supranuclear palsy. Neurology 1997, 49(4):999-1003.
46. Sixel-Döring F., Schweitzer M., Mollenhauer B., Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med 2009, 10(4):407-415.
47. Gama R.L., Távora D.G., Bomfim R.C., Silva C.E., de Bruin V.M., de Bruin P.F. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy-a comparative study. Parkinsonism Relat Disord 2010, 16(4):275-279.
48. Shub D., Darvishi R., Kunik M.E. Non-pharmacologic treatment of insomnia in persons with dementia. Geriatrics 2009, 64:22-26.
49. Foley D., Ancoli-Israel S., Britz P., Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004, 56(5):497-502.
50. Pandi-Parumal S.R., Seils L.K., Kayumov L., Ralph M.R., Lowe A., Moller H., et al. Senescence, sleep, and circadian rhythms. Ageing Res Rev 2002, 1:559-604.
51. Elwood P., Hack M., Pickering J., Hughes J., Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006, 60(1):69-73.
52. Chen Y.K., Lu J.Y., Mok V.C., Ungvari G., Chu W.C., Wong K.S., et al. Clinical and radiologic correlates of insomnia symptoms in ischemic stroke patients. Int J Geriatr Psychiatry 2010, 10.1002/gps.2547.
53. Leppavuori A., Pohjasvaara T., Vataja R., Kaste M., Erkinjuntti T. Insomnia in ischemic stroke patients. Cerebrovasc Dis 2002, 14(2):90-97.
54. Fichtenberg N.L., Zafonte R.D., Putnam S., Mann N.R., Millard A.E. Insomnia in a post-acute brain injury sample. Brain Inj 2002, 16:197-206.
55. Kempf J., Werth E., Kaiser P.R., Bassetti C.L., Baumann C.R. Sleep-wake disturbances 3 years after traumatic brain injury. J Neurol Neurosurg Psychiatry 2010, 81(12):1402-1405.
56. Ayalon L., Borodkin K., Dishon L., Kanety H., Dagan Y. Circadian rhythm sleep disorders following mild traumatic brain injury. Neurology 2007, 68(14):1136-1140.
57. Verma A., Anand V., Verma N.P. Sleep disorders in chronic traumatic brain injury. J Clin Sleep Med 2007, 3(4):357-362.
58. Parcell D.L., Ponsford J.L., Rajaratnam S.M., Redman J.R. Self-reported changes to nighttime sleep after traumatic brain injury. Arch Phys Med Rehabil 2006, 87:278-285.
59. Dikmen S., McLean A., Temkin N. Consequences of minor head injury. Neuropsychological and psychosocial. J Neurol Neurosurg Psychiatry 1986, 49:1227-1232.
60. Williams B., Lazic S.E., Olgivie R.D. Polysomnographic and quantitative EEG analysis of subjects with long-term insomnia complaints associated with mild traumatic brain injury. Clin Neurophysiol 2008, 119:429-438.
61. Guilleminault C., Yuen K.M., Gulevich M.G., Karadeniz D., Leger D., Philip P. Hypersomnia after head-neck trauma: a medico-legal dilemma. Neurology 2000, 54(3):653-659.
62. Beetar J.T., Guilmette T.J., Sparadeo F.R. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch Phys Med Rehabil 1997, 78(4):451.
63. Kaufmann Y., Tzischinsky O., Epstein R., Etzioni A., Lavie P., Pillar G. Long-term sleep disturbances in adolescents after minor head injury. Pediatr Neurol 2001, 24(2):129-134.
64. Quellet M.C., Morin C.M. Subjective and objective measures of brain injury: a preliminary study. Sleep Med 2006, 7(6):486-497.
65. Baumann C.R., Werth E., Stocker R., Ludwig S., Bassetti C.L. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 2007, 130:1873-1883.
66. Herman S.T. Epilepsy and sleep. Curr Treat Options Neurol 2006, 8(4):271-279.
67. Khatami R., Zutter D., Siegel A., Mathis J., Donati F., Bassetti C.L. Sleep-wake habits and disorders in a series of 100 adult epilepsy patients-a prospective study. Seizure 2006, 15(5):299-306.
68. Piperidou C., Karlavasitou A., Triantafyllou N., Terzoudi A., Mavraki E., Trypsianis G., et al. Influence of sleep disturbance on quality of life of patients with epilepsy in Greece. Qual Life Res 2008, 17(7):987-996.
69. De Weerd A., de Haas S., Otte A., Trenité D.K., van Erp G., Cohen A., et al. Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life. Epilepsia 2004, 45:1397-1404.
70. Miller M.T., Vaughn B.V., Messenheimer J.A., Greenwood R.S., Egan T.M., D'Cruz O.F., et al. Subjective sleep quality in patients with epilepsy. Epilepsia 1996, 36(Suppl. 4):43.
71. Abad-Alegria E., Lopez-Mallen M.E., de Francisco-Maquedea P. Insomnia and somnolence in epilepsy. Rev Neurol 1997, 25:1171-1172.
72. Sadler M. Lamotrigine associated with insomnia. Epilepsia 1999, 40(3):322-325.
73. Manni R., Terzaghi M. Comorbidity between epilepsy and sleep disorders. Epilepsy Res 2010, 90(3):171-177.
74. Paiva T., Esperanca P., Martins I., Batista A., Martins P. Sleep disorders in headache patients. Headache 1992, 3:438-442.
75. Kelman L., Rains J.C. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache 2005, 45:904-910.
76. Alstadhaug K.B., Bekkelund S., Salvesen R. Circannual periodicity of migraine?. Eur J Neurol 2007 Sep, 14(9):983-988.
77. Maizels M., Burchette R. Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and co-morbidity. Headache 2004, 44:983-993.
78. Rothrock J., Patel M., Lyden P., Jackson C. Demographic and clinical characteristics of patients with episodic migraine versus chronic daily headache. Cephalalgia 1996, 16:44-49.
79. Boardman H.F., Thomas E., Millson D.S., Croft P.R. Psychological, sleep, lifestyle, and co-morbid associations with headache. Headache 2005, 45:657-669.
80. Alberti A., Mazzotta G., Gallinella E., Sarchielli P. Headache characteristics in obstructive sleep apnea and insomnia. Acta Neurol Scand 2005, 111:309-316.
81. Baltzan M.A., Kassissia I., Elkholi O., Palayew M., Dabrusin R., Wolkove N. Prevalence of persistent sleep apnea in patients treated with continuous positive airway pressure. Sleep 2006, 29:557-563.
82. Nobre M.E., Leal A.J., Filho P.M. Investigation into sleep disturbance of patients suffering from cluster headache. Cephalalgia 2005, 25:488-492.
83. Graff-Radford S.B., Newman A. Obstructive sleep apnea and cluster headache. Headache 2004, 44:607-610.
84. Bamer A.M., Johnson K.L., Amtmann D., Kraft G.H. Prevalence of sleep problems in individuals with multiple sclerosis. Mult Scler 2008, 14(8):1127-1130.
85. Tachibana H., Howard R.S., Hirsch N.P., Miller D.H., Moseley I.F., Fish D. Sleep problems in multiple sclerosis. Mult Scler 2006, 12(4):481-486.
86. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992, 258:806-808.
87. Montagna P. Fatal familial insomnia: clinical, laboratory and pathological features. Rev Neurol 1999, 29:1006-1009.
88. 18FDG-PET studies. Brain 2006, 129:668-675.
89. Riemann D., Perlis M.L. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 2009, 13:205-214.
90. Lyons K.E., Friedman J.H., Hermanowicz N., Isaacson S.H., Hauser R.A., Hersh B.P., et al. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects. Clin Neuropharmacol 2010, 33(1):5-10.
91. Ondo W.G., Perkins T., Swick T., Hull K.L., Jimenez J.E., Gerry T.S., et al. Sodium oxybate for excessive daytime sleepiness in Parkinsons disease. Archiv Neurol 2009, 65(10):1337-1340.
92. Cicolin A., Lopiano L., Zibetti M., Torre E., Tavella A., Guastamacchia G., et al. Effects of deep brain stimulation of the subthalamic nucleus on sleep architecture in parkinsonian patients. Sleep Med 2004, 5(2):207-210.
93. Arnulf I., Bejjani B.P., Garma L., Bonnet A.M., Houeto J.L., Damier P., et al. Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55(11):1732-1734.
94. Morgante L., Epifanio A., Spina E., Di Rosa A.E., Zappia M., Basik G., et al. Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis. Clin Neuropharmacol 2004, 27:153-156.
95. Leeman A.L., O'Neill C.J., Nicholson P.W., Deshmuk A.A., Denham M.J., Royston J.P., et al. Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987, 24:637-643.
96. Stocchi F., Barbato L., Nordera G., Berardelli A., Ruggieri S. Sleep disorders in Parkinson's disease. J Neurol 1998, 245(Suppl. 1):S15-S18.
97. Dowling G.A., Mastick J., Colling E., Carter J.H., Singer C.M., Aminoff M.J. Melatonin for sleep disturbances in Parkinson's disease. Sleep Med 2005, 6:459-466.
98. Medeiros C.A., Carvalhedo de Bruin P.F., Lopes L.A., Magalhaes M.C., de Lourdes Seabra M., de Bruin V.M. Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: a randomized, double blind, placebocontrolled study. J Neurol 2007, 254:459-464.
99. Forbes D., Culum I., Lischka A.R., Morgan D.G., Peacock S., Forbes J., et al. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementia. Cochrane Database Syst Rev 2009, 4. CD003946.
100. Ancoli-Israel S., Martin J.L., Gehrman P., Shochat T., Corey Bloom J., Marler M., et al. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 2003, 11:194-203.
101. Dowling G.A., Burr R.L., Van Someren E.J., Hubbard E.M., Luxenberg J.S., Mastick J., et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008, 56:239-246.
102. McCurry S.M., Gibbons L.E., Logsdon R.G., Vitielleo M.V., Teri L. Nighttime insomnia treatment and education for Alzheimer's disease. J Am Geriatr Soc 2005, 53(5):793-802.
103. Sack R.L., Auckley D., Auger R.R., Carskadon M.A., Wright K.P., Vitiello M.V., et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. Sleep 2007, 30(11):1484-1501.
104. Singer C., Tractenberg R.E., Kaye J., Schafer K., Gamst A., Grundmann M., et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep 2003, 26(7):893-901.
105. Riemersma-van der Lek R.F., Swaab D.F., Tiwsk J., Hol E.M., Hoogendijk W.J., Van Someren E.J. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008, 299:2642-2655.
106. Cotroneo A., Gareri P., Nicoletti N., Lacava R., Grassone D., Maina E., et al. Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. Arch Gerontol Geriatr 2007, (Suppl. 1):121-124.
107. Lee H., Kim S.W., Kim J.M., Shin I.S., Yang S.J., Yoon J.S. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol 2005, 20(2):97-104.
108. Kemp S., Biswas R., Neumann V., Coughlan A. The value of melatonin for sleep disorders occurring post-head injury: a pilot RCT. Brain Inj 2004, 8(9):911-919.
109. Quellet M.C., Morin C.M. Efficacy of cognitive-behavioral therapy for insomnia associated with traumatic brain injury: a single-case experimental design. Arch Phys Med Rehabil 2007, 88(12):1581-1592.
110. Palomaki H., Berg A., Meririnne E., Kaste M., Lonnqvist R., Lehtihalmes M., et al. Complaints of poststroke insomnia and its treatment with mianserin. Cerebrovasc Dis 2003, 15(1-2):56-62.
111. Li Pi Shan R.S., Ashwort N.L. Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blind trial. Am J Phy Med Rehabil 2004, 83:421-427.
112. Rains J.C., Poceta S. Headache and sleep disorders: review and clinical implications for headache management. Headache 2006, 46:1344-1363.
113. Calhoun A.H., Ford S. Behavioral sleep modification may revert transformed migraine to episodic migraine. Headache 2007, 47:1178-1183.
114. Baron K.G., Corden M., Jin L., Mohr D.C. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med 2010, 10.1007/s10865-010-9288-2.
115. Julien J., Vital C., Delisle M., Géraud G. FFI around the world: the French FFI cases. Brain Pathol 1998, 8:555-558.
116. Will R.G., Campbell J., Moss T.H., Bell J., Ironside J. FFI cases from the United Kingdom. Brain Pathol 1998, 8:562-563.
117. Reder A.T., Mednick A.S., Brown P., Spire J.P., Van Cauter E., Wollmann R.L., et al. Clinical and genetic studies of fatal familial insomnia. Neurology 1995, 45:1068-1075.
118. Schenkein J., Montagna P. Self-management of fatal familial insomnia. Part 2: case report. MedGenMed 2006, 8(3):66.